About
Sanodyne Therapeutics is developing innovative oral low-molecular compounds for treating peripheral neuropathy and neuropathic pain, focusing on novel mechanisms distinct from existing therapies.
Explore Sanodyne Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.